BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20214538)

  • 21. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive prenatal diagnosis: current practice and future perspectives.
    Hahn S; Chitty LS
    Curr Opin Obstet Gynecol; 2008 Apr; 20(2):146-51. PubMed ID: 18388814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive prenatal diagnosis: past, present, and future.
    Litton C; Stone J; Eddleman K; Lee MJ
    Mt Sinai J Med; 2009 Dec; 76(6):521-8. PubMed ID: 20014413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma.
    Meaney C; Norbury G
    Prenat Diagn; 2009 Dec; 29(13):1218-21. PubMed ID: 19844939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of intact fetal cells in maternal plasma by real-time PCR.
    Zhong XY; Hahn S; Steinborn A; Holzgreve W
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):20-4. PubMed ID: 16949194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prenatal gene diagnosis of paternally inherited alpha-thalassemia by detecting fetal DNA in maternal plasma].
    Chen P; Li MJ; Li MQ; Li SQ; Zhou LY; Lin WX
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1540-4. PubMed ID: 17785106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of maternal plasma for noninvasive determination of fetal RhD status.
    Harper TC; Finning KM; Martin P; Moise KJ
    Am J Obstet Gynecol; 2004 Nov; 191(5):1730-2. PubMed ID: 15547554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.
    Li Y; Hahn S; Holzgreve W
    Ann N Y Acad Sci; 2006 Dec; 1092():285-92. PubMed ID: 17308152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in fetal DNA in maternal plasma.
    Chiu RW; Lo YM
    Ann N Y Acad Sci; 2004 Jun; 1022():100-4. PubMed ID: 15251946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fetal DNA in maternal blood].
    Rijnders RJ; Christiaens GC; de Haas M; van der Schoot CE
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):170-4. PubMed ID: 14974307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience.
    González-González C; Garcia-Hoyos M; Trujillo-Tiebas MJ; Lorda-Sanchez I; de Alba MR; Infantes F; Gallego J; Diaz-Recasens J; Ayuso C; Ramos C
    J Histochem Cytochem; 2005 Mar; 53(3):307-14. PubMed ID: 15750008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
    Li Y; Holzgreve W; Hahn S
    Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].
    Sesarini C; Giménez ML; Redal MA; Izbizky G; Aiello H; Argibay P; Otaño L
    Arch Argent Pediatr; 2009 Oct; 107(5):405-9. PubMed ID: 19809760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
    Lo YM
    BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-beta-thalassemia.
    Tungwiwat W; Fucharoen G; Fucharoen S; Ratanasiri T; Sanchaisuriya K; Sae-Ung N
    Transl Res; 2007 Nov; 150(5):319-25. PubMed ID: 17964521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic developments involving cell-free (circulating) nucleic acids.
    Tong YK; Lo YM
    Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New non-invasive technique for prenatal diagnosis: analysis of maternal blood].
    Costa JM
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S48-9. PubMed ID: 12592163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.